EVNIN ANTHONY B

CIK 00012392413 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001239241

Recent Transactions

33 trades

Award
RENOVIS INC
Nonstatutory Stock Option (Right to Buy)
2006-01-16+11,111→ 11,111 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series C Convertible Preferred Stock
2004-04-08−393,600→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+190,697→ 535,523 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+201,555→ 472,983 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+274,418→ 747,401 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+204,762→ 204,762 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+140,064→ 344,826 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+14,233→ 14,233 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+271,428→ 271,428 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series D Convertible Preferred Stock
2004-04-08−823,256→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+190,697→ 535,523 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+271,428→ 271,428 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series C Convertible Preferred Stock
2004-04-08−393,600→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+274,418→ 747,401 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series B Convertible Preferred Stock
2004-04-08−614,286→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series C Convertible Preferred Stock
2004-04-08−40,000→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series C Convertible Preferred Stock
2004-04-08−566,400→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series B Convertible Preferred Stock
2004-04-08−814,286→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series D Convertible Preferred Stock
2004-04-08−572,093→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+201,555→ 472,983 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series B Convertible Preferred Stock
2004-04-08−614,286→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series C Convertible Preferred Stock
2004-04-08−566,400→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+204,762→ 204,762 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series B Convertible Preferred Stock
2004-04-08−814,286→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series D Convertible Preferred Stock
2004-04-08−823,256→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series C Convertible Preferred Stock
2004-04-08−40,000→ 0 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+140,064→ 344,826 total
Conversion
MEMORY PHARMACEUTICALS CORP
Common Stock
2004-04-08+14,233→ 14,233 total
Conversion
MEMORY PHARMACEUTICALS CORP
Series D Convertible Preferred Stock
2004-04-08−572,093→ 0 total
Award
MEMORY PHARMACEUTICALS CORP
Stock Option (Right to Buy)
2004-04-05+20,000→ 20,000 total
Award
MEMORY PHARMACEUTICALS CORP
Stock Option (Right to Buy)
2004-04-05+20,000→ 20,000 total
Other
OTIX GLOBAL, INC.
Common Stock
2004-02-17+5,996→ 27,657 total
Other
OTIX GLOBAL, INC.
Common Stock
2004-02-17+5,545→ 33,202 total

Companies

Recent Filings

Address

C/O VENROCK ASSOCIATES 30 ROCKEFELLER PLAZA, ROOM 5508

NEW YORK, NY, 10112

View on SEC.gov